Evidence map›Paper›PMID 32425906›Full record

ArticleFrontiers in microbiology2020

Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota.

Zhongmei Sun, Junxiang Li, Yi Dai, Wenting Wang, Rui Shi, Zhibin Wang, Panghua Ding, Qiongqiong Lu, Hui Jiang, Wenjing Pei and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Pharmaceutical biology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Journal of pharmacopuncture · 2024
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Zhongmei SunGraduate School, Beijing University of Chinese Medicine, Beijing, China.
Junxiang LiDepartment of Gastroenterology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Yi DaiDepartment of Pharmacy, School of Pharmacy, Hyogo University of Health Sciences, Kobe, Japan.
Wenting WangDepartment of Traditional Chinese Medicine, Beijing Yangfangdian Hospital, Beijing, China.
Rui ShiDepartment of Gastroenterology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Zhibin WangDepartment of Gastroenterology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Panghua DingGraduate School, Beijing University of Chinese Medicine, Beijing, China.
Qiongqiong LuGraduate School, Beijing University of Chinese Medicine, Beijing, China.
Hui JiangDepartment of Gastroenterology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Wenjing PeiDepartment of Gastroenterology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Xingjie ZhaoDepartment of Gastroenterology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Yi GuoDepartment of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Jiali LiuGraduate School, Beijing University of Chinese Medicine, Beijing, China.
Xiang TanDepartment of Gastroenterology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Tangyou MaoDepartment of Gastroenterology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Beijing University of Chinese Medicine · CNDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CNHyogo University of Health Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ulcerative colitis is a gastrointestinal disorder intricately associated with intestinal dysbiosis, but effective treatments are currently limited. Indigo naturalis, a traditional Chinese medicine derived from indigo plants, has been widely used in the treatment of ulcerative colitis. However, the specific mechanisms have not yet been identified. Accordingly, in this study, we evaluated the effects and mechanisms of indigo naturalis on dextran sulfate sodium (DSS)-induced colitis in rats. Our results showed that indigo naturalis potently alleviated DSS-induced colitis in rats, and reversed DSS-induced intestinal dysbiosis using bacterial 16S rRNA amplicon sequencing. The protective effects of indigo naturalis were gut microbiota dependent, as demonstrated by antibiotic treatments and fecal microbiota transplantation. Depletion of the gut microbiota through a combination of antibiotic treatments blocked the anti-inflammatory effect of indigo naturalis on the DSS-induced colitis, and the recipients of the gut microbiota from indigo naturalis-treated rats displayed a significantly attenuated intestinal inflammation, which was actively responsive to therapeutic interventions with indigo naturalis. Notably, supplement with indigo naturalis greatly increased the levels of feces butyrate, which was positively correlated with the relative abundances of

Indexed as

butyratedextran sulfate sodiumgut microbiotaindigo naturalisulcerative colitis

Identifiers

PMID32425906
PMCPMC7203728
OpenAlexW3015279851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.